Tax code weaponized to block employer coverage of abortion travel and gender care

What it does

This bill amends the tax code to prohibit employers from deducting business expenses when they reimburse employees for travel to obtain an abortion or for gender transition procedures for minor children. The bill defines gender transition procedures in detail, including surgeries, hormone treatments, and puberty blockers, while carving out exceptions for treatment of disorders of sex development and emergency medical care. Employers who currently offer these benefits as part of health or wellness programs would lose the tax deduction for those specific reimbursements.

Why we flagged it

The bill's operative mechanism is a tax deduction denial—a financial penalty on employers who offer specific health benefits. It is not primarily a regulatory restriction on medical practice (which would be within state authority) but rather a federal tax code amendment designed to discourage employer coverage of two politically contested services: abortion travel and gender transition care for minors.

What the text implies

• The bill may disproportionately affect employees at large corporations and progressive employers who currently offer abortion travel reimbursement, reducing their compensation package and making these employers less competitive for talent.
• By targeting the tax deduction rather than the underlying medical services, the bill creates a federal tax incentive structure that discourages private health coverage of these services without directly banning them—a form of indirect regulation through the tax code.
• The detailed medical definitions (puberty blockers, cross-sex hormones, specific surgical procedures) embedded in the tax code establish federal tax law as a de facto medical classification system, potentially creating conflicts with state medical boards and FDA-approved treatments.
• Employers may respond by narrowing health plan coverage more broadly to avoid the deduction denial, affecting employee access to other health services and reducing the value of employer-sponsored insurance.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill restricts employers' ability to offer abortion travel reimbursement and gender transition coverage for minors, reducing employee access to these benefits and narrowing the scope of employer-sponsored health coverage. While framed as preventing 'radical activism,' the operative effect is to make it financially disadvantageous for employers to offer these specific health benefits, thereby reducing employee choice and access to medical care and reproductive services.

Named in the bill

Internal Revenue Service, Section 162 of the Internal Revenue Code, employers, employees

Where it stands

• Feb 11, 2025 — Introduced · Congress.gov: “Introduced in House”
• Feb 11, 2025 — Referred to House Committee on Ways and Means · Congress.gov: “Referred to the House Committee on Ways and Means”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $439,908 in lobbying spend. A filing names 132 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Brian Mast, the sponsor, reported $378,866 in PAC receipts in the 2026 cycle.

• Human Rights Campaign — $439,908 on 2 filings

Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.